EyePoint Pharmaceuticals, Inc. — Director's Dealing 2017

Dec 19, 2017

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: pSivida Corp. (PSDV)
CIK: 0001314102
Period of Report: 2017-12-15

Reporting Person: Godshall Douglas Evan (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2017-12-15	Employee Stock Option (right to buy)	$1.77	A	20000	Acquired	2027-06-27	Common Stock (20000)	Direct
2017-12-15	Deferred Stock Units	$	A	12500	Acquired		Common Stock (12500)	Direct

Footnotes

F1: Each deferred stock unit represents the right to receive one share of the common stock of pSivida Corp. (the "Company").

F2: Subsequent to the vesting of the deferred stock units, the deferred stock units will be settled in shares of the Company's common stock upon the earliest to occur of: (i) the reporting person's termination of service on the Company's Board of Directors and (ii) the occurrence of a "change in control" (as defined in the applicable award agreement) that constitutes a "change in the ownership or effective control of" the Company or "a change in the ownership of a substantial portion of the assets of" the Company, in each case, as determined under Section 409A of the Internal Revenue Code of 1986, as amended, and the regulations issued thereunder.